Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Raymond Turner

Neurological Surgery Billings, MT Medical Doctor

NPI 1992980973 CMS profile 363147

1041 N 29Th St, Billings, MT 59101

Open in the dashboard

General payments

$1,322,476

354 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$538,270

7 holdings reported · through program year 2025

Research they led as principal investigator

$13,944 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Raymond Turner of Billings, MT is reported in the CMS Open Payments database as having received $1,322,476 across 354 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $13,944 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $538,270 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,084 9
2024 General $52,147 27
2023 General $114,034 37
2022 General $97,030 47
2021 General $122,449 35
2020 General $146,966 84
2019 General $768,766 115
2025 Ownership $14,982 1
2024 Ownership $84,846 1
2023 Ownership $84,846 1
2022 Ownership $74,505 1
2021 Ownership $225,623 2
2020 Ownership $53,469 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Raymond Turner
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Raymond Turner were reported at $21,084. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Raymond Turner Neurological Surgery median Middle half National median
2019 $768,766 $582 $138–$3,006 $163
2020 $146,966 $294 $76–$2,174 $114
2021 $122,449 $387 $105–$2,432 $132
2022 $97,030 $542 $139–$2,989 $149
2023 $114,034 $534 $145–$2,697 $160
2024 $52,147 $574 $155–$3,046 $164
2025 $21,084 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corindus Inc. $530,001 7 payments
  2. Siemens Medical Solutions USA, Inc. $287,485 163 payments
  3. Medtronic, Inc. $214,732 68 payments
  4. Biosense Webster, Inc. $166,089 29 payments
  5. Medical Device Business Services, Inc. $60,297 14 payments
  6. Qapel Medical Inc $37,189 6 payments
  7. Rapid Medical LTD $10,536 3 payments
  8. Medtronic USA, Inc. $8,361 13 payments
  9. Integra LifeSciences Corporation $3,424 7 payments
  10. Boston Scientific Corporation $1,125 1 payment
  11. Other $3,238 43 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Current or prospective ownership or investment interest $529,485 1 payment
  2. Consulting Fee $398,576 48 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $362,961 126 payments
  4. Travel and Lodging $21,915 41 payments
  5. Food and Beverage $9,515 137 payments
  6. Gift $24 1 payment
Products named General payments · program years 2019–2025
  1. Pipeline $14,694 19 payments
  2. CorPath Imaging System $13,345 9 payments
  3. TIGERTRIEVER 17 REVASCULARIZATION DEVICE $10,536 3 payments
  4. COMANECI 17 $10,536 3 payments
  5. Artis icono $8,557 14 payments
  6. INTELLIS ADAPTIVESTIM $6,931 2 payments
  7. Covidien-Access $6,800 1 payment
  8. Artis icono floor $3,396 1 payment
  9. CUSA CLARITY $1,300 2 payments
  10. CODMAN CERTAS $1,300 2 payments
  11. Other $15,137 112 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$26,283

Medicare's payments for the services billed

Medicare patients

62

Average age 75

Services billed

137

45 women, 17 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 47%
Depression 44%
Diabetes 35%
Chronic kidney disease 34%
Ischemic heart disease 27%
Atrial fibrillation 27%
COPD 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

354 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Montana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record